Work

Continuation of TTFields after recurrence in patients with glioblastoma may be associated with prolonged post-recurrence survival

Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Purpose The efficacy of tumor-treating fields (TTFields) in newly diagnosed glioblastoma is established, but the benefit of continuing treatment after first recurrence remains unclear. This study evaluated the association between TTFields continuation and survival after recurrence. Methods This single-center retrospective cohort study included consecutive patients with newly diagnosed supratentorial glioblastoma who received TTFields between April 2018 and December 2025. TTFields were initiated with maintenance temozolomide after standard chemoradiation. At first radiographic progression, patients chose whether to continue or discontinue TTFields. Post-recurrence survival and overall survival from surgery were analyzed using the Kaplan–Meier method and Cox proportional hazards models. TTFields adherence (≥ 75% vs. <75%) was also evaluated. Results Of 39 TTFields-treated patients, three without recurrence and one with missing usage data were excluded, leaving 35 for analysis: 15 continued treatment after recurrence and 20 discontinued it. Baseline characteristics did not differ significantly between groups. Overall survival from surgery did not differ significantly (median, 35 vs. 20 months; p = 0.104), whereas post-recurrence survival was longer in the continuation group (median, 11 vs. 9 months; p = 0.0434). Survival did not differ significantly by adherence (≥ 75% vs. <75%). In multivariable Cox proportional hazards analysis adjusted for age, sex, and adherence, continued TTFields use remained associated with longer post-recurrence survival (adjusted hazard ratio, 0.376; 95% confidence interval, 0.150–0.943; p = 0.0370). Conclusion Continuing TTFields after first recurrence was associated with longer post-recurrence survival. This association persisted after adjustment for age, sex, and adherence, although the retrospective design and small sample size limit causal interpretation.
Institution: Kyoto University
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W7235075986
Cites: 27
Cited by:
Related to: 10